Targeted nanoparticles boost arsenic's anticancer punch
Links shared publicly online about this topic.
- 1,880total visits
Targeted nanoparticles boost arsenic's anticancer punch
Arsenic trioxide has a long history as a potent human poison, but it also has proven valuable as one of the primary treatment options for acute promyelocytic leukemia. Efforts to use arsenic trioxide to treat other types of cancer are under way, but clinical trials are revealing that the extreme toxicity of this material is likely to limit its utility as a broad-spectrum anticancer agent.
View full resource at news-medical.net
Tags: Emergency, Poison, Cancer, Leukemia, Clinical Trial, Oncology, News
Most Recently Shared on July 22, 2009 at 7:51 am By:
Oncology News: Targeted nanoparticles boost arsenic’s anticancer punch: Arsenic trioxide has a lon.. http://cli.gs/bYYZV
Targeted Nanoparticles Boost Arsenic's Anticancer Punch
physorg.com — “Arsenic trioxide has a long history as a potent human poison, but it also has proven valuable as one of the primary treatment options for acute promyelocytic leukemia. Efforts to use arsenic trioxide to treat other types of cancer are under way, but clinical trials are revealing that the extreme toxicity ...” View full resource at physorg.com
Most Recently Shared on July 22, 2009 at 5:47 pm By:
Targeted Nanoparticles Boost Arsenic`s Anticancer Punch http://bit.ly/fyaRx
Advertisement
